Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Yahoo Finance
4 weeks ago • Google News
Catalyst Pharmaceuticals Inc (CPRX)
US$ 24.11-0.86%
Price Chart
Key Statistics
Market Cap
$ 2.56B
P/E Ratio
13.34
Revenue (TTM)
$ 534.65M
Volume
901.21K
52W High
$ 26.58
52W Low
$ 15.34
Dividend Yield
0.00%
Beta
0.72
Technicals
50-Day MA
23.4788
200-Day MA
22.4112
52 Week High
26.58
52 Week Low
15.34
About CPRX
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
Employees
181
Headquarters
Coral Gables, FL
CEO
Mr. Richard John Daly M.B.A.
Latest News
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock - Nasdaq
4 weeks ago • Google News
Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth - simplywall.st
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg